3/27
08:41 am
mirm
LIVMARLI Now Approved in Japan for ALGS and PFIC [Yahoo! Finance]
Low
Report
LIVMARLI Now Approved in Japan for ALGS and PFIC [Yahoo! Finance]
3/27
08:30 am
mirm
LIVMARLI Now Approved in Japan for ALGS and PFIC
Low
Report
LIVMARLI Now Approved in Japan for ALGS and PFIC
3/24
05:20 pm
mirm
Mirum Pharmaceuticals: Set Fair For Share Price Momentum - Reversing My Sell Call [Seeking Alpha]
Low
Report
Mirum Pharmaceuticals: Set Fair For Share Price Momentum - Reversing My Sell Call [Seeking Alpha]
3/21
08:09 pm
mirm
Mirum's Heavy Dependence on Livmarli for Revenues Remains a Woe [Yahoo! Finance]
Low
Report
Mirum's Heavy Dependence on Livmarli for Revenues Remains a Woe [Yahoo! Finance]
3/10
08:00 pm
mirm
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/1
07:07 pm
mirm
Analyst Estimates: Here's What Brokers Think Of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) After Its Full-Year Report [Yahoo! Finance]
Medium
Report
Analyst Estimates: Here's What Brokers Think Of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) After Its Full-Year Report [Yahoo! Finance]
2/28
08:13 am
mirm
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) had its price target raised by analysts at HC Wainwright from $66.00 to $72.00. They now have a "buy" rating on the stock.
Low
Report
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) had its price target raised by analysts at HC Wainwright from $66.00 to $72.00. They now have a "buy" rating on the stock.
2/27
11:16 am
mirm
Q4 2024 Mirum Pharmaceuticals Inc Earnings Call [Yahoo! Finance]
Low
Report
Q4 2024 Mirum Pharmaceuticals Inc Earnings Call [Yahoo! Finance]
2/27
10:40 am
mirm
Mirum Pharmaceuticals (MIRM): Among the Best Performing Mid Cap Stocks to Buy According to Analysts [Yahoo! Finance]
Low
Report
Mirum Pharmaceuticals (MIRM): Among the Best Performing Mid Cap Stocks to Buy According to Analysts [Yahoo! Finance]
2/27
10:40 am
mirm
Mirum Pharmaceuticals Inc (MIRM) Q4 2024 Earnings Call Highlights: Record Sales Surge and ... [Yahoo! Finance]
Low
Report
Mirum Pharmaceuticals Inc (MIRM) Q4 2024 Earnings Call Highlights: Record Sales Surge and ... [Yahoo! Finance]
2/27
10:40 am
mirm
Wall Street Analysts Predict a 26.18% Upside in Mirum Pharmaceuticals (MIRM): Here's What You Should Know [Yahoo! Finance]
Low
Report
Wall Street Analysts Predict a 26.18% Upside in Mirum Pharmaceuticals (MIRM): Here's What You Should Know [Yahoo! Finance]
2/27
08:08 am
mirm
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) had its price target raised by analysts at Robert W. Baird from $50.00 to $55.00. They now have an "outperform" rating on the stock.
Medium
Report
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) had its price target raised by analysts at Robert W. Baird from $50.00 to $55.00. They now have an "outperform" rating on the stock.
2/26
04:36 pm
mirm
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update [Yahoo! Finance]
2/26
04:01 pm
mirm
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update
Medium
Report
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update
2/24
09:17 am
mirm
Mirum's CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX) [Yahoo! Finance]
Medium
Report
Mirum's CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX) [Yahoo! Finance]
2/24
08:30 am
mirm
Mirum’s CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX)
Medium
Report
Mirum’s CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX)
2/19
04:04 pm
mirm
Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call on February 26, 2025
Low
Report
Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call on February 26, 2025
2/10
07:00 pm
mirm
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/6
08:00 am
mirm
Genomenon and Mirum Pharmaceuticals Join Forces to Enhance CTX Disease Awareness and Diagnosis
Medium
Report
Genomenon and Mirum Pharmaceuticals Join Forces to Enhance CTX Disease Awareness and Diagnosis
1/15
12:51 pm
mirm
Trending Tickers [Yahoo! Finance]
Low
Report
Trending Tickers [Yahoo! Finance]
1/15
10:01 am
mirm
Metagenomi Announces New Appointment to its Board of Directors [Yahoo! Finance]
Low
Report
Metagenomi Announces New Appointment to its Board of Directors [Yahoo! Finance]
1/13
08:30 am
mirm
Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates
High
Report
Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates
1/10
06:30 pm
mirm
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/6
04:04 pm
mirm
Mirum Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Low
Report
Mirum Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference